Non-HDL-cholesterol and atherogenicity in type 2 diabetes mellitus patients
Metabolism(2022)
摘要
Background: In type 2 diabetes mellitus (DM) lipoprotein abnormalities are the main contributors resulting high atherogenic dyslipidaemia. Non-HDL-cholesterol could be used in screening patients with diabetes, especially in whom LDL-cholesterol levels may not be significantly elevated.
更多查看译文
关键词
diabetes mellitus, atherogenic index, non-HDL-cholesterol
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要